Growth, nutrition, and cytokine response of breast-fed infants and infants fed formula with added bovine osteopontin

Journal of Pediatric Gastroenterology and Nutrition

Volumn 62, Issue 4, 2016, Pages 650-657

  Lonnerdal, Bo ^a   Kvistgaard, Anne S ^b   Peerson, Janet M ^a   Donovan, Sharon M ^c   Peng, Yong Mei ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Arla Foods   (Denmark)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d FUDAN UNIVERSITY   (China)

Author keywords

Cytokines; Infant formula; Iron status; Osteopontin; Pyrexia

Indexed keywords

AMINO ACID; ANTIBODY; ASPARAGINE; ASPARTIC ACID; BRANCHED CHAIN AMINO ACID; C REACTIVE PROTEIN; CYTOKINE; FERRITIN; GLUTAMIC ACID; GLUTAMINE; INSULIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; IRON; ISOLEUCINE; LEUCINE; LYSINE; METHIONINE; NITROGEN; OSTEOPONTIN; THREONINE; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA; UREA; VALINE; MILK PROTEIN;

AMINO ACID BLOOD LEVEL; ANTHROPOMETRY; ANTIBODY BLOOD LEVEL; ARTICLE; ARTIFICIAL MILK; BLOOD SAMPLING; BODY HEIGHT; BODY WEIGHT; BOVINE; BREAST FEEDING; BREAST MILK; CHILD GROWTH; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RESPONSE; DIETARY INTAKE; DOWN REGULATION; EVALUATION STUDY; FEMALE; FERRITIN BLOOD LEVEL; HEAD CIRCUMFERENCE; HEMOGLOBIN DETERMINATION; HUMAN; INFANT; INFANT NUTRITION; INSULIN BLOOD LEVEL; IRON BLOOD LEVEL; MALE; MILK PRODUCTION; NEWBORN MORBIDITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; UREA NITROGEN BLOOD LEVEL; ADVERSE EFFECTS; ANIMAL; BLOOD; CHEMISTRY; CHILD DEVELOPMENT; CHINA; DOUBLE BLIND PROCEDURE; FEVER; GROWTH, DEVELOPMENT AND AGING; HOSPITAL; IMMUNE SYSTEM; IMMUNOLOGY; INCIDENCE; METABOLISM; NEWBORN; NUTRITIONAL STATUS; PREVALENCE;

AMINO ACIDS; ANIMALS; BLOOD UREA NITROGEN; BREAST FEEDING; CATTLE; CHILD DEVELOPMENT; CHINA; CYTOKINES; DOUBLE-BLIND METHOD; FEMALE; FEVER; HOSPITALS, PEDIATRIC; HUMANS; IMMUNE SYSTEM; INCIDENCE; INFANT FORMULA; INFANT, NEWBORN; MALE; MILK PROTEINS; NUTRITIONAL STATUS; OSTEOPONTIN; PREVALENCE;

EID: 84944338847     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000001005     Document Type: Article

References (39)

1. ESPGHAN Committee on Nutrition Agostoni C, Braegger C, Decsi T, et al. Breast-feeding: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2009;49:112-25.
2. Weng SF, Redsell SA, Swift JA, et al. Systematic review and meta-analyses of risk factors for childhood overweight identifiable during infancy. Arch Dis Child 2012;97:1019-26.
3. Owen CG, Whincup PH, Cook DG. Breast-feeding and cardiovascular risk factors and outcomes in later life: evidence from epidemiological studies. Proc Nutr Soc 2011;70:478-84.
4. Patelarou E, Girvalaki C, Brokalaki H, et al. Current evidence on the associations of breastfeeding, infant formula, and cow's milk introduction with type 1 diabetes mellitus: a systematic review. Nutr Rev 2012;70:509-19.
5. Cardwell CR, Stene LC, Ludvigsson J. Breast-feeding and childhood-onset type 1 diabetes: a pooled analysis of individual participant data from 43 observational studies. Diabetes Care 2012;35:2215-25.
6. Owen CG, Martin RM, Whincup PH, et al. Does breastfeeding influence risk of type 2 diabetes in later life? A quantitative analysis of published evidence. Am J Clin Nutr 2006;84:1043-54.
7. Fewtrell MS. Breast-feeding and later risk of CVD and obesity: evidence from randomised trials. Proc Nutr Soc 2011;70:472-7.
8. Lönnerdal B. Infant formula and infant nutrition: bioactive proteins of human milk and implications for composition of infant formulas. Am J Clin Nutr 2014;99:712S-7S.
9. Standal T, Borset M, Sundan A. Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp Oncol 2004;26:179-84.
10. Dhanireddy R, Senger D, Mukherjee BB, et al. Osteopontin in human milk of premature mothers. Acta Paediatr 1993;82:821-2.
11. Nagatomo T, Ohga S, Takada H, et al. Microarray analysis of human milk cells: persistent high expression of osteopontin during the lactation period. Clin Exp Immunol 2004;138:47-53.
12. Sørensen S, Justesen SJ, Johnsen AH. Purification and characterization of osteopontin from human milk. Protein Expr Purif 2003;30:238-45.
13. Bayless KJ, Davis GE, Meininger GA. Isolation and biological properties of osteopontin from bovine milk. Protein Expr Purif 1997;9:309-14.
14. Sørensen ES, Højrup P, Petersen TE. Post-translational modifications of bovine osteopontin: identification of twenty-eight phosphorylation and three O-glycosylation sites. Protein Sci 1995;4:2040-9.
15. Ashkar S, Weber GF, Panoutsakopoulou V, et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000;287: 860-4.
16. Giachelli CM, Lombardi D, Johnson RJ, et al. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 1998;152:353-8.
17. Hwang SM, Lopex CA, Heck DE, et al. Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J Biol Chem 1994;69:11-5.
18. Nau GJ, Liaw L, Chupp GL, et al. Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin. Infect Immun 1999;67:4223-30.
19. Pabst HF, Godel J, Grace M, et al. Effect of breast-feeding on immune response to BCG vaccination. Lancet 1989;1:295-7.
20. Nau GJ, Chupp GL, Emile JP, et al. Osteopontin expression correlates with clinical outcome in patients with mycobacterial infection. Am J Pathol 2000;157:37-42.
21. Burkey TE, Skjolaas KA, Dritz SS, et al. Expression of Toll-like receptors, interleukin 8, macrophage migration inhibitory factor, and osteopontin in tissues from pigs challenged with Salmonella enterica serovar or typhimurium or serovar choleraesuis. Vet Immunol Immuno-pathol 2007;115:309-19.
22. Da Silva AP, Pollett A, Rittling SR, et al. Exacerbated tissue destruction in DSS-induced acute colitis of OPN-null mice is associated with downregulation of TNF-alpha expression and non-programmed cell death. J Cell Physiol 2006;208:629-39.
23. Rollo EE, Hempson SJ, Bansal A, et al. The cytokine osteopontin modulates the severity of rotavirus diarrhea. J Virol 2005;79: 3509-16.
24. Dewey KG, Heinig MJ, Nommsen LA, et al. Growth of breast-fed and formula-fed infants from 0 to 18 months: the DARLING Study. Pediatrics 1992;89:1035-41.
25. Domellöf M, Dewey KG, Lönnerdal B, et al. The diagnostic criteria for iron deficiency in infants should be reevaluated. J Nutr 2002;132: 3680-6.
26. Chaparro CM, Neufeld LM, Tena Alavez G, et al. Effect of timing of umbilical cord clamping on iron status in Mexican infants: a randomised controlled trial. Lancet 2006;367:1997-2004.
27. Hernell O, Lönnerdal B. Iron status of infants fed low iron formula: no effect of added bovine lactoferrin or nucleotides. Am J Clin Nutr 2002;76:858-64.
28. Koletzko B, Beyer J, Brands B, et al., European Childhood Obesity Trial Study Group. Early influences of nutrition on postnatal growth. Nestle Nutr Inst Workshop Ser 2013;71:11-27.
29. Räihä NC, Axelsson IE. Protein nutrition during infancy. An update. Pediatr Clin North Am 1995;42:745-64.
30. Boehm G, Cervantes H, Georgi G, et al. Effect of increasing dietary threonine intakes on amino acid metabolism of the central nervous system and peripheral tissues in growing rats. Pediatr Res 1998;44: 900-6.
31. Timby N, Domellöf E, Hernell O, et al. Neurodevelopment, nutrition and growth until 12 months of age in infants fed a low energy low protein formula supplemented with bovine milk fat globule membranes. A randomized controlled trial. Am J Clin Nutr 2014;99: 860-8.
32. Kainonen E, Rautava S, Isolauri E. Immunological programming by breast milk creates an anti-inflammatory cytokine milieu in breast-fed infants compared to formula-fed infants. Br J Nutr 2012;30:1-9.
33. Lönnerdal B, Du X, Morris K, et al. TGFb2 in human milk and infant formula resists digestion in a suckling rat pup model. J Pediatr Gastroenterol Nutr 2010;50 (suppl 2):E199.
34. Heinrich PC, Behrmann I, Haan S, et al. Principles of interleukin-6-type cytokine signalling and its regulation. Biochem J 2003;374(pt 1): 1-20.
35. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001;104: 487-501.
36. Dorman SE, Holland SM. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev 2000;11: 321-33.
37. Newport MJ, Holland SM, Levin M, et al. Inherited disorders of the interleukin-12/23-interferon gamma axis. In: Ochs HD, Smith CI, Puck J, eds. Primary Immunodeficiency Diseases: A Molecular and Genetic Approach. New York: Oxford University Press; 2007:390-401.
38. Temblay JN, Bertelli E, Arques JL, et al. Production of IL-12 by Peyer patch-dendritic cells is critical for the resistance to food allergy. J Allergy Clin Immunol 2007;120:659-65.
39. Malek TR, Castro I. Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 2010;33:153-65.